首页> 外国专利> TARGET VALIDATION AND PROFILING OF THE RNA TARGETS OF SMALL MOLECULES

TARGET VALIDATION AND PROFILING OF THE RNA TARGETS OF SMALL MOLECULES

机译:小分子的RNA靶标的靶标验证和表达

摘要

A method for the precise cellular destruction of an oncogenic non-coding RNA with a RNA-binding small molecule conjugated with bleomycin A5 is described. The method affords reversal of phenotype. Bleomycin A5 was coupled to an RNA-binding molecule that selectively binds the microRNA-96 hairpin precursor (pri-miR-96). By coupling of bleomycin A5's free amine to the RNA-binding molecule, its affinity for binding to pri-miR- 96 is 100-fold stronger than to DNA. The conjugate compound selectively cleaves pri-miR- 96 in triple negative breast cancer (TNBC) cells. Selective cleavage of pri-miR-96 enhances expression of FOXO1 protein, a pro-apoptotic transcription factor that miR-96 silences, and triggers apoptosis in TNBC cells. No effects were observed in healthy breast epithelial cells. This method provides programmable control for targeting RNA through the selection of an RNA-binding molecule/bleomycin A5 conjugate and provides a facile method of mapping the cellular binding sites of an RNA-binding molecule.
机译:描述了一种用与博来霉素A5缀合的RNA结合小分子精确地破坏致癌非编码RNA的方法。该方法提供了表型的逆转。博来霉素A5与选择性结合microRNA-96发夹前体(pri-miR-96)的RNA结合分子偶联。通过将博来霉素A5的游离胺与RNA结合分子偶联,其与pri-miR-96结合的亲和力比对DNA的亲和力强100倍以上。缀合物选择性地在三阴性乳腺癌(TNBC)细胞中裂解pri-miR-96。 pri-miR-96的选择性切割增强了FOXO1蛋白的表达,FOXO1蛋白是一种促凋亡的转录因子,miR-96沉默并触发TNBC细胞凋亡。在健康的乳腺上皮细胞中未观察到影响。该方法通过选择RNA结合分子/博来霉素A5缀合物提供了靶向RNA的可编程控制,并且提供了绘制RNA结合分子的细胞结合位点的简便方法。

著录项

  • 公开/公告号WO2020076511A1

    专利类型

  • 公开/公告日2020-04-16

    原文格式PDF

  • 申请/专利权人 THE SCRIPPS RESEARCH INSTITUTE;

    申请/专利号WO2019US53179

  • 发明设计人 DISNEY MATTHEW D.;

    申请日2019-09-26

  • 分类号C40B30;C40B40;C40B40/06;C12N15/113;A61K47/54;A61K47/55;

  • 国家 WO

  • 入库时间 2022-08-21 11:11:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号